More women can access anti-cancer shot

The Age

August 4, 2009

The Australian-developed vaccine which offers protection against cervical cancer has been approved for use by women up to the age of 45.

The Therapeutic Goods Administration has approved broader access to Gardasil, which has been involved in a national immunisation program taking in females aged 12 to 26.

Developed by 2006 Australian of the Year Professor Ian Frazer, Gardasil offers protection against four strains of the Human Papilloma Virus.


Comment from Leslie

To the best of my knowledge and research – this age group was not tested in the trials.  Women with weakened immune and endocrine systems because of age will be sujected to this vaccine with dire consequences.


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.